SABCS 2022 Conference Coverage


 

SABCS 2022 Primary Results From the Randomized Phase II RIGHT Choice Trial: Premenopausal Patients With Aggressive HR+/HER2- Advanced BC Treated With Ribociclib + ET vs. Physician’s Choice Combination Chemo

212 views
January 20, 2023
Comments 0
Login to view comments. Click here to Login